-
Je něco špatně v tomto záznamu ?
Synthesis and anti-trypanosomal activity of 3'-fluororibonucleosides derived from 7-deazapurine nucleosides
VH. Nguyen, M. Tichý, S. Rožánková, R. Pohl, AM. Downey, E. Doleželová, E. Tloušťová, M. Slapničková, A. Zíková, M. Hocek
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
33741462
DOI
10.1016/j.bmcl.2021.127957
Knihovny.cz E-zdroje
- MeSH
- fibroblasty účinky léků MeSH
- lidé MeSH
- molekulární struktura MeSH
- nádorové buněčné linie MeSH
- parazitické testy citlivosti MeSH
- ribonukleosidy chemická syntéza farmakologie toxicita MeSH
- trypanocidální látky chemická syntéza farmakologie toxicita MeSH
- Trypanosoma brucei brucei účinky léků MeSH
- Trypanosoma brucei gambiense účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Trypanosoma brucei parasites cause Human African Trypanosomiasis and the current drugs for its treatment are often inefficient and toxic. This urges the need to development of new antitrypanosomal agents. We report the synthesis and biological profiling of 3'-deoxy-3'-fluororibonucleosides derived from 7-deazaadenine nucleosides bearing diverse substituents at position 7. They were synthesized through glycosylation of 6-chloro-7-bromo- or -7-iodo-7-deazapurine with protected 3'-fluororibose followed by cross-coupling reactions at position 7 and/or deprotection. Most of the title nucleosides displayed micromolar or submicromolar activity against Trypanosoma brucei brucei. The most active were the 7-bromo- and 7-iododerivatives which exerted double-digit nanomolar activity against T. b. brucei and T. b. gambiense and no cytotoxicity and thus represent promising candidates for further development.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025736
- 003
- CZ-PrNML
- 005
- 20211026133546.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bmcl.2021.127957 $2 doi
- 035 __
- $a (PubMed)33741462
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Nguyen, Van Hai $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic; Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 8, CZ-12843 Prague 2, Czech Republic
- 245 10
- $a Synthesis and anti-trypanosomal activity of 3'-fluororibonucleosides derived from 7-deazapurine nucleosides / $c VH. Nguyen, M. Tichý, S. Rožánková, R. Pohl, AM. Downey, E. Doleželová, E. Tloušťová, M. Slapničková, A. Zíková, M. Hocek
- 520 9_
- $a Trypanosoma brucei parasites cause Human African Trypanosomiasis and the current drugs for its treatment are often inefficient and toxic. This urges the need to development of new antitrypanosomal agents. We report the synthesis and biological profiling of 3'-deoxy-3'-fluororibonucleosides derived from 7-deazaadenine nucleosides bearing diverse substituents at position 7. They were synthesized through glycosylation of 6-chloro-7-bromo- or -7-iodo-7-deazapurine with protected 3'-fluororibose followed by cross-coupling reactions at position 7 and/or deprotection. Most of the title nucleosides displayed micromolar or submicromolar activity against Trypanosoma brucei brucei. The most active were the 7-bromo- and 7-iododerivatives which exerted double-digit nanomolar activity against T. b. brucei and T. b. gambiense and no cytotoxicity and thus represent promising candidates for further development.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a fibroblasty $x účinky léků $7 D005347
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a parazitické testy citlivosti $7 D021261
- 650 _2
- $a ribonukleosidy $x chemická syntéza $x farmakologie $x toxicita $7 D012263
- 650 _2
- $a trypanocidální látky $x chemická syntéza $x farmakologie $x toxicita $7 D014344
- 650 _2
- $a Trypanosoma brucei brucei $x účinky léků $7 D014346
- 650 _2
- $a Trypanosoma brucei gambiense $x účinky léků $7 D014347
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tichý, Michal $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic
- 700 1_
- $a Rožánková, Samanta $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic
- 700 1_
- $a Pohl, Radek $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic
- 700 1_
- $a Downey, A Michael $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic
- 700 1_
- $a Doleželová, Eva $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 31, CZ-37005 České Budějovice, Czech Republic
- 700 1_
- $a Tloušťová, Eva $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic
- 700 1_
- $a Slapničková, Martina $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 31, CZ-37005 České Budějovice, Czech Republic
- 700 1_
- $a Zíková, Alena $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 31, CZ-37005 České Budějovice, Czech Republic. Electronic address: azikova@paru.cas.cz
- 700 1_
- $a Hocek, Michal $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, CZ-16000 Prague 6, Czech Republic; Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 8, CZ-12843 Prague 2, Czech Republic. Electronic address: hocek@uochb.cas.cz
- 773 0_
- $w MED00000770 $t Bioorganic & medicinal chemistry letters $x 1464-3405 $g Roč. 40, č. - (2021), s. 127957
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33741462 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133553 $b ABA008
- 999 __
- $a ok $b bmc $g 1714669 $s 1146243
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 40 $c - $d 127957 $e 20210317 $i 1464-3405 $m Bioorganic & medicinal chemistry letters $n Bioorg Med Chem Lett $x MED00000770
- LZP __
- $a Pubmed-20211013